Comparative Bioavailability of Sublingual TNX-102, Oral and Intravenous Cyclobenzaprine in Healthy Adults

NCT01634412 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Adults

Interventions

DRUG: SL TNX-102 2.4 mg at pH 3.5
DRUG: SL TNX-102 2.4 mg at pH 7.1
DRUG: Cyclobenzaprine Tablet
DRUG: Cyclobenzaprine IV

Sponsor

Tonix Pharmaceuticals, Inc.